Omada Health's GLP-1 Program Projected to Deliver $11,142 in Per-Member Savings Over Five Years
Event summary
- Independent model estimates Omada’s GLP-1 program could save up to $11,142 per member in gross medical costs over five years.
- Members persisting on GLP-1 for 12+ months saw 30% higher savings compared to 6-month persistence.
- Engaged members (9.5+ weekly actions) saved an additional $1,891 at year five.
- Reductions in new-onset type 2 diabetes (49%) and hypertension (28%) contributed to cumulative savings.
The big picture
Omada Health’s GLP-1 program underscores the growing emphasis on virtual-first, between-visit care models for chronic conditions like obesity and diabetes. The independent cost savings model reinforces the strategic shift toward long-term health outcomes over short-term cost avoidance, aligning with employer demands for accountable care solutions. With over two million members served, Omada is positioning itself as a key player in the evolving landscape of digital health and chronic disease management.
What we're watching
- Program Adoption
- Whether Omada can sustain high member engagement and persistence rates to maximize long-term savings.
- Market Differentiation
- How Omada’s evidence-backed approach will position it against competitors in the GLP-1 therapy space.
- Employer Demand
- The pace at which employers adopt Omada’s program as a cost-effective solution for chronic care management.